Minocycline inhibits hyperpolarization-activated currents in rat substantia gelatinosa neurons

Neuropharmacology
Nana LiuTao Liu

Abstract

Minocycline is a widely used glial activation inhibitor that could suppress pain-related behaviors in a number of different pain animal models, yet, its analgesic mechanisms are not fully understood. Hyperpolarization-activated cation channel-induced Ih current plays an important role in neuronal excitability and pathological pain. In this study, we investigated the possible effect of minocycline on Ih of substantia gelatinosa neuron in superficial spinal dorsal horn by using whole-cell patch-clamp recording. We found that extracellular minocycline rapidly decreases Ih amplitude in a reversible and concentration-dependent manner (IC50 = 41 μM). By contrast, intracellular minocycline had no effect. Minocycline-induced inhibition of Ih was not affected by Na(+) channel blocker tetrodotoxin, glutamate-receptor antagonists (CNQX and D-APV), GABAA receptor antagonist (bicuculine methiodide), or glycine receptor antagonist (strychnine). Minocycline also caused a negative shift in the activation curve of Ih, but did not alter the reversal potential. Moreover, minocycline slowed down the inter-spike depolarizing slope and produced a robust decrease in the rate of action potential firing. Together, these results illustrate a novel cellu...Continue Reading

References

Jul 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Vivien Chevaleyre, Pablo E Castillo
May 8, 2003·The Journal of Pharmacology and Experimental Therapeutics·Vasudeva RaghavendraJoyce A DeLeo
Mar 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ingrid van WelieWytse J Wadman
Apr 2, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thanh N DoanDiana L Kunze
Apr 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Flobert Y TangaJoyce A DeLeo
Sep 30, 2005·Journal of Neurophysiology·Aldo Rogelis A Rodrigues, Donata Oertel
May 12, 2006·European Journal of Pharmacology·Taraneh Moini ZanjaniBabak Farokhi
May 13, 2006·The Journal of Physiology·Yexica ApontePeter Jonas
Jul 18, 2006·FEBS Letters·Samuel A Owolabi, Carl Y Saab
Aug 25, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hirokazu KatsuraKoichi Noguchi
Jan 24, 2007·The Journal of Pharmacology and Experimental Therapeutics·Toshiyuki MizushimaKoichi Noguchi
Mar 3, 2007·The Journal of Physiology·Sónia F A SantosBoris V Safronov
Nov 8, 2007·The European Journal of Neuroscience·José Carlos GonzálezJesús M Hernández-Guijo
May 30, 2008·Journal of Neurophysiology·Michele DibattistaAnna Menini
Aug 8, 2008·Brain, Behavior, and Immunity·Joanna MikaBarbara Przewlocka
Oct 22, 2008·The Journal of Physiology·Aliakmal MominPeter A McNaughton
Jul 9, 2009·Physiological Reviews·Martin BielXiangang Zong
Sep 25, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bi-Wen PengRussell M Sanchez
Apr 27, 2010·The Journal of Pain : Official Journal of the American Pain Society·Yu-Wen Chang, Stephen G Waxman
Aug 13, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marilena GriguoliEnrico Cherubini
Nov 18, 2010·Brain Research·Tae Hoon KimJin-Ho Song
Dec 29, 2010·PloS One·Matthew J Van Hook, David M Berson
Sep 10, 2011·Science·Edward C EmeryPeter A McNaughton

❮ Previous
Next ❯

Citations

Jan 13, 2016·Anesthesia and Analgesia·Tao HuTao Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.